Novartis AG Research and Development Expenses 2010-2024 | NVS
Novartis AG research and development expenses for the twelve months ending June 30, 2024 were $11.280B, a 22.17% increase year-over-year.
- Novartis AG annual research and development expenses for 2023 were $11.371B, a 23.98% increase from 2022.
- Novartis AG annual research and development expenses for 2022 were $9.172B, a 3.86% decline from 2021.
- Novartis AG annual research and development expenses for 2021 were $9.54B, a 6.24% increase from 2020.